We used six other immune infiltration algorithms and found that the low-risk group had a richer infiltration of anti-tumor immune cells, such as CD8+ T cells, CD4+ T cells, active NK cells and B cells (Figure 7D). The gene discussed is CD8A; the disease is neoplasm.